The left atrium (LA) transfers blood to the left ventricle in a complex manner. LA function is characterized by passive emptying (LA passive fraction), active emptying (LA ejection fraction), and total emptying (LA fractional change). Despite this complexity, the clinical relevance of the LA is based almost exclusively on LA maximal volume (LAmax), which may not glean the full prognostic potential. Cardiovascular magnetic resonance (CMR) is considered the most accurate method for studying LA function and size. The aim of the present study was to evaluate the prognostic importance of LA function in patients following ST elevation myocardial infarction (STEMI).
Introduction
The left atrium (LA) dilates in response to either chronic volume overload or chronic pressure overload, and can in the absence of volume overload be considered a marker for chronically increased left ventricular (LV) filling pressure. 1 -3 Increased LA maximal volume (LAmax) is an important prognostic predictor in a variety of cardiac diseases including acute myocardial infarction. 4 -12 However, the transferal of blood from the LA to the LV is complex, and comprises several phases: passive emptying (LA passive fraction), active emptying [LA ejection fraction (LAEF)], and total emptying (LA fractional change). Despite this complexity, the clinical relevance of LA is based almost exclusively on LAmax or merely maximal diameter assessed by two-dimensional or M-mode echocardiography. Cardiovascular magnetic resonance (CMR) is considered the gold standard for measuring volumes of cardiac chambers, 13, 14 and thus the most accurate means for studying the importance of LA volume and function. 14 -17 Previously, impaired LA function assessed by CMR has been demonstrated to be a prognostic predictor in patients with hypertension and suspected ischaemia. 18, 19 However, clinical and prognostic information of LA function after acute ischaemia are limited. LAmax does not seem to be affected by acute ischaemia, whereas LA function is altered by acute ischaemia and acute changes in LV filling. 20 Recently, using computed tomography, Kühl et al. 21 have demonstrated that impaired LA function is associated with a poorer prognosis in patients with non ST-segment elevation myocardial infarction (NSTEMI). However, patients with NSTEMI often have a more longstanding history of ischaemic heart disease, increased prevalence of comorbidities, smaller acute ischaemic burden, and a different prognosis from those with STEMI. 22 Thus, the potential prognostic information of LA function in patients with STEMI remains unknown. We hypothesized that LA function may provide important prognostic information for predicting outcome in patients with STEMI. The purpose of the present study was to determine the prognostic importance of LA function and volume assessed by CMR in patients following STEMI.
Methods

Study population
Patients in the present study underwent a CMR examination as part of a randomized study of patients with STEMI comparing intravenous administration of exenatide with placebo. 23 Exenatide is a synthetic analogue to glucagon-like-peptide-1 that is used in diabetics and also suggested to be cardioprotective. Patients were enrolled if they had their first STEMI with duration of symptoms ≤12 h and had the LA assessed by CMR. STEMI was defined as ST elevation in two contiguous ECG leads of .0.1 mV in V 4 -V 6 or leads II, III, and aVF, or .0.2 mV in leads V 1 -V 3 . The patients were not considered for enrolment if they presented with cardiogenic shock or were unconscious. Patients with stent thrombosis, renal insufficiency, or previous coronary artery bypass graft surgery and in case where cardiac biomarkers did not confirm the diagnosis were excluded. Furthermore, patients with known paroxysmal, persistent, or chronic atrial fibrillation any time before or during CMR were also excluded from this study. Cardiac biomarkers (troponin T) were obtained before, immediately after, 6, and 12 -18 h after intervention. All patients were admitted directly to the catheterization laboratory where a primary percutaneous coronary intervention (PCI) was performed and medical treatment initiated as previously described. 23 All patients were informed verbally and in writing, and gave written consent before inclusion.
The study was performed according to the Helsinki declaration of good clinical practice, and The Danish National Committee on Biomedical Research Ethics approved the protocol (protocol number: 01 326257). In order to asses LV diastolic function with echocardiography, experienced sonographers using the Philips IE33 Ultrasound System (Philips Healthcare, DA Best, The Netherlands) measured mitral inflow with pulsed wave Doppler, lateral mitral annulus motion using pulsed-wave tissue Doppler, and LAmax from the apical four-and two-chamber views. From mitral inflow and tissue Doppler, the peak E and diastolic e ′ were measured. Diastolic dysfunction was graded as normal, mild, moderate, or severe as suggested by guidelines for evaluating LV diastolic function. 24 The presence of mitral regurgitation was assessed with colour Doppler echocardiography. Using the proximal isovelocity surface area method, no patients had moderate or severe mitral regurgitation (effective regurgitant orifice area .0.2 cm 2 ).
CMR acquisition and analysis
CMR was performed as previously described. 23 The patients were screened for contraindications for CMR, and if none existed, a CMR scan was performed within a median of 2 [inter-quartile range (IQR): 1 -3] days after the STEMI on a 1.5 T scanner (Avanto scanner, Siemens, Erlangen, Germany). LV and LA volumes were assessed using a steady-state free precession cine sequence (slice thickness 8 mm, slice gap 0 mm, echo time 1.5 ms, field of view 300 -360 mm, phases 25). Multiple slices in the short-axis image plane were obtained covering the entire LV and LA. 14 Final infarct size was assessed after a second CMR scan performed within a median of 89 (IQR: 80 -93) days after index STEMI using a delayed enhancement sequence. These images were obtained 10 min after intravenous injection of 0.1 mg/kg body weight gadoliniumdiethlenetriamine pentaacetic acid (Gadovist, Bayer Schering, Berlin, Germany), using an inversion-recovery sequence (slice thickness 8 mm, slice gap 0 mm, echo time 1.4 ms, field of view 300 -360 mm, slice gap 0 mm). The area at risk was assessed on the first scan as oedema using a T2-weighted short tau inversion recovery sequence (slice thickness 15 mm, field of view 300-360 mm, inversion time 180 ms, repetition time 2 R to R intervals, time to echo 65 ms, slice gap 0 mm). The LV diastolic and systolic phases were automatically identified on cine CMR images according to the LV blood pool area. LV end-diastolic volume, LV end-systolic volume, and LV ejection fraction (LVEF) were calculated by manually tracing the endocardial border at end-systole, and end-diastole including the papillary muscles as part of the LV cavity. The border between the LA and the LV was defined as the atrio-ventricular plane, which was identified in the four -and twochamber image planes ( Figure 1) . Furthermore, lumen surrounded by thick myocardium was not considered as part of LA. In each time frame, in each short-axis slice, the LA endocardial border was manually traced (Figure 1) , and the total LA volume was calculated for each time frame. The appendage was accounted as part of the LA volume. All LV and LA volumes were standardized according to body surface area. The analysis was performed with an ARGUS post-processing tool (ARGUS, Siemens). Interobserver variability was assessed in 50 patients, and the mean percentage error was 3 + 10% for LAmin, 4 + 8% for LAmax, 1 + 11% for LA fractional change, and 1 + 22% for LAEF. 25 Final infarct size was assessed using the freely available software Segment v1.8 (http://segment.heiberg.se). 26 The endocardial and epicardial borders were manually traced in all short-axis images and the LV mass was calculated. The infarct size, defined as the hyperenhanced myocardium on the delayed enhancement images, was determined by an automatic approach. 26 The area at risk was defined as the hyperintense area on T2-weighted images. A myocardial area was regarded as hyperintense when the signal intensity was higher than 2 standard deviations of the signal intensity in the normal myocardium. The salvage index was calculated as follows: (area at risk -infarct size)/ area at risk.
LA volume and function in patients following STEMI
LA volume and function
LA time -volume curves were constructed for every patient in order to identify the following pre-specified volumes: LAmin, LAmax, LA minimal mid-diastolic volume, and LA pre-systolic volume ( Figure 2 ). 15,21 LA mid-diastolic volume was defined as the smallest LA volume measured between LAmax and LA volume before LA systole. The passive emptying was assessed as LA passive volume (LAmax -LA minimal mid-diastolic volume), and LA passive fraction (LA passive volume/LAmax). The active LA emptying was assessed as LA stroke volume (LA pre-systolic volume -LAmin), and LAEF (LA stroke volume/LA pre-systolic volume). Total emptying is assessed as cyclic change (LAmax -LAmin), and LA fractional change (cyclic change/LAmax).
Clinical endpoint
The primary clinical endpoint was major adverse cardiac event (MACE) defined as all-cause mortality, any re-infarction, stroke, and any admission for heart failure (peripheral or pulmonary oedema). Data were collected from hospital files and from the Danish Civil Registration system.
Statistical analysis
All statistical analyses were performed with SPSS software version 20 (SPSS Inc., Chicago, IL, USA). A two-sided P-value of ,0.05 was considered statistically significant. Categorical variables were compared using x 2 or Fisher's exact test and continuous variables using Student's t-test or the Mann-Whitney. All continuous variables were tested for normal distribution and parametric or non-parametric statistics used accordingly. To identify variables associated with LA volumes, linear regression analyses were performed and correlation coefficients calculated. Highly skewed variables were logarithmically transformed. All non-LA variables were used.
To assess the survival free of MACE for tertiles of LAmax, LAmin, LA fractional change, LA passive fraction, and LAEF, the Kaplan-Meier method was used and differences were tested with the log-rank test. In order to identify independent predictors for MACE, the multivariable Cox proportional hazard regression analyses were performed for LAmin, LAmax, LAEF, LA stroke volume, LA passive fraction, LA passive volume, cyclic change, and LA fractional change adjusting for all variables with a P-value of ,0.05 in the univariable analysis (Model 1). Furthermore, a Cox proportional hazard analysis was also performed adjusting for known prognostic predictors [age, LVEF, anterior infarct location, thrombolysis in myocardial infarction (TIMI) flow, and symptom onset-to-balloon duration] (Model 2). The overall Wald x 2 of nested models containing all variables with P , 0.05 in the univariable analysis and LAmax were compared with the overall Wald x 2 of models including all aforementioned variables and LAEF, LA passive fraction, and LA fractional change, separately. Only one LA parameter was used for each analysis. The risk for MACE was expressed as the hazard ratio with 95% confidence interval. In the case of expected co-linearity, only the best in the univariable analysis will be used in the multivariable approach. The Cox regression assumptions were checked for each variable by interaction, variable × variable (linearity-only continuous variable) and visually for proportionality.
Results
A total of 387 patients with STEMI were randomized in the exenatide trial and 199 patients had available LA data and were thus included in this study ( Figure 3) . Table 1 shows the clinical characteristics of the study population and of the excluded patients. Some patients were lost to the second CMR leaving 163 patients with final infarct size (median ¼ 9%LV IQR: 6-15%LV). Echocardiography data were available from 155 patients. Thus, the regression analyses using final infarct size or echocardiography-based measurements were performed only in these patients (n ¼ 163 and 155, respectively). In all, the remaining statistical analysis all 199 patients were used unless other is indicated.
Predictors for LA volume and function
The association of clinical and LV variables with LA volume and function is shown in Table 2 . LAmax mostly seems to reflect longstanding cardiovascular conditions such as age, LV mass index, LV end-diastolic volume index, and diastolic dysfunction grade, and was not related to more acute markers of LV disease such as peak troponin T, area at risk, reduced LVEF, infarct size, and the ratio between early mitral inflow velocity to early diastolic mitral annular lengthening velocity (E/e ′ ). In contrast, LAmin, LA fractional change, and LA passive fraction seem to reflect both preexisting cardiovascular conditions (age, previous PCI, LV mass index, LV end-diastolic volume index, and diastolic dysfunction grade), and acute LV disease related to the STEMI (peak troponin T, area at risk, LVEF, infarct size, and E/e ′ ).
Predictors of outcome
During the follow-up period of 2.3 years (IQR: 2.0 -2.5), a total of 40 patients (20%) met the clinical endpoint of MACE (4 patients died due to a cardiac cause, 6 patients died of a non-cardiac cause, 20 patients were admitted due to heart failure, 6 patients suffered a re-infarction, and 4 patients a stroke). In the KaplanMeier analysis, a high LAmin tertile was associated with MACE, whereas a high LAmax was not ( Figure 4) . A low value of LA fractional change and LA passive fraction were associated with MACE, whereas a trend towards an association between a high LAEF and MACE was observed (Figure 4 ). In the univariable Cox regression analysis, LAmax had a borderline significant P-value of 0.07 for predicting MACE (Table 3) , whereas LAmin, LA passive fraction, LAEF, LA stroke volume, cyclic change, and LA fractional change all were significantly associated with MACE ( Table 3 ). The unadjusted value of a 10% change in LA fractional change is shown in Figure 5 . Age, hypertension, previous PCI, LVEF, E/e ′ , and diastolic dysfunction grade were also significantly associated with outcome in the univariable analysis ( 
Discussion
This is the first study to evaluate LA function in patients following STEMI. By the use of CMR, the main findings of this study are: (i) LA fractional change, LA passive fraction, and LAmin reflect acute and chronic heart disease, whereas LAmax mainly reflects chronic heart disease; and (ii) LA fractional change provides independent prognostic information beyond known predictors.
LA volume and function
The LA convey blood from the pulmonary veins to the LV. The blood accumulates in the LA against a closed mitral valve in the reservoir phase (ventricular systole). The passive emptying phase, during early LV diastole, is caused by LV recoil and relaxation, and the active emptying phase is caused by active LA contraction. Due to equalizing of pressure between the chambers during mitral valve opening, increased LV diastolic pressure will cause LA pressure overload and LA dilatation. LA volume and function in patients following STEMI lead to a decrease in LA stroke volume. On Doppler echocardiography, this corresponds to pseudonormalization of the E-and A-waves. This bimodal response in LA active contribution may explain that no clear pattern was observed in terms of the association between LAEF and LV function in the present study. In patients with acute ischaemia, this is further complicated by an increase in LA contraction through increased LA volume before LA systole and the Frank -Starling mechanism, without changing LA stroke volume, but leading to decreased LAEF. 29 More information on LA physiology can be found elsewhere. 30 In this study, LAmax was not associated with acute LV function, suggesting that LAmax enlargement mainly is determined by preexisting conditions, which is supported by the association of LAmax with age and LV mass. In contrast, LAmin, LA passive fraction, and LA fractional change were all associated with preexisting conditions and acute LV functional parameters as well as diastolic and systolic dysfunction, suggesting that these LA parameters are sensitive towards immediate functional changes in LV diastolic and systolic function in addition to the chronic burden. This is in accordance with results from animal studies showing that LA total filling decreases and LAmin but not LAmax increased due to acute ischaemia. 20 This is explained by a combination of reduced LV longitudinal fibre shortening and increased LA compliance leading to a reduction in LA filling.
LA and outcome
In this study, LA fractional change provided independent prognostic information in the multivariate models as well as incremental information to known predictors, which is in accordance with a previous study in NSTEMI patients. 21 Unfortunately, echocardiography measurements were not available from all patients, which is a limitation to this study. It has previously been suggested that the poorer outcome in patients with increased LAmax is related to preexisting increased filling pressure, which in the setting of acute myocardial infarction is poorly tolerated. 5, 11 In contrast, LA fractional change seems to reflect both longstanding LV disease and acute instantaneous changes in the LV function, which probably explains the strong prognostic value of LA fractional change in STEMI patients. LAmin has previously been found superior to LAmax in terms of predicting outcome in other cardiac diseases. 18, 31 In this study, LAmin did also seem to be a stronger predictor than LAmax, most likely due to the closer association with acute LV functional parameters. An additional explanation is that impaired LA function is closer associated with the development of atrial fibrillation than increased LA volume, 32 and development of atrial fibrillation following an acute myocardial infarction is associated with outcome. 33 As opposed to previous studies, 18, 21 LAEF did not provide a strong prognostic information in the present study. This could be explained by a difference in endpoints, 18, 21 disease (STEMI vs.
NSTEMI and chronic hypertension), 18, 21 imaging modality (CMR vs. computed tomography), 21 and difference in the assessment of LA volumes (short axis vs. two-and four-chamber). 18 Chronic hypertension exposes the heart to longstanding haemodynamic changes and not acute changes as in the case of STEMI. Furthermore, STEMI patients have less comorbidity, lower LVEF, and larger infarct sizes than NSTEMI patients. 22 Thus, STEMI patients have more conspicuous immediate haemodynamic changes than NSTEMI and chronic hypertensive patients, but they are also less likely to have chronic LV diastolic burden.
Imaging modality
CMR is considered the gold standard for assessing cardiac chamber sizes and is being used increasingly in clinical practice and studies. This study demonstrates that applying 4-6 additional slices in the short-axis image view provides interesting prognostic information, which may serve as a surrogate endpoint in clinical studies looking into LV function. There exists other imaging method for assessment of LA volume and function. Although computed tomography generally overestimates the LA volumes compared with CMR, there is still a good correlation between the two modalities. 17, 25 However, in contrast to computed tomography, CMR is a radiation-free method that also allows for accurate detection of myocardial infarction size. 34 Echocardiography is more accessible and more widely used in clinical practice than both CMR and computed tomography. The assessment of LA function by echocardiography is hampered by a higher inter-and intraobserver variability and that the heart changes its position during a cardiac cycle. LA volume is traditionally assessed using two-dimensional echocardiography, which is known to underestimate LA volumes, and correlate only moderately with CMR, 17 which however may be improved by using three-dimensional echocardiography. 35 Future studies are warranted to evaluating LA functional imaging.
Limitations
Patients excluded present some of the most critically ill (e.g. patients with renal failure, prior coronary artery bypass surgery, atrial fibrillation, prior myocardial infarction, unconsciousness, and cardiogenic shock), which introduces the risk of selection bias. This may also help explain that LAmax, LV end-diastolic volume, LV end-systolic volume, multiple vessel disease, anterior infarct location, and thrombolysis in myocardial infarction grade were not significantly associated with outcome. However, the excluded patients are also more likely to have LA dysfunction. It Model 2: only one LA parameter was included in the model at the time. Adjusted for age, LVEF, anterior infarct location, heart rate, TIMI flow, and symptom onset-to-balloon duration.
is, therefore, questionable that having CMR data from all STEMI patients would lead to a different conclusion, and it just emphasizes the high sensitivity of LA fractional change. Another reason may be that 50% of the events were admission for heart failure. However, 84% of patients who die after an acute myocardial infarction have symptoms and signs of heart failure preceding death, 36 and patients who are continuously admitted for heart failure is at risk of dying of heart failure. 37, 38 In the present study, the LA was measured in the short-axis image view, which is challenging in terms of detecting the atrioventricular border. This approach was used based on previous experience, 14 -16,35 but it may be easier to identify the atrioventricluar plane in the axial or longitudinal image plane. Final infarct size was not available in all 199 patients, and gadolinium was not given during the first scan. Thus, infarct size and microvascular obstruction could therefore not be evaluated and included in the outcome analysis. Final infarct size was not used in the outcome analysis, since this will rule out any patients suffering an event between discharge and 3 months. Paroxysmal or sustained atrial fibrillation is associated with adverse outcome, 39 and patients with known atrial fibrillation before the time of CMR were therefore excluded from this study. However, this does not rule out patients with unknown subclinical atrial fibrillation, which recently has been associated with adverse outcome. 40 Due to relatively small sample size and many statistical comparisons, it is possible that some significant differences were observed by chance. The statistical power of the study is low with a risk of overfitting the multivariate models and risk of Type II error due to multiple comparisons, and thus the results should be interpreted with this in mind.
Conclusions
In STEMI patients, impaired LA fractional change is independently associated with outcome and provide incremental prognostic information to established predictors including LAmax.
